miRNAs in Critical Limb Ischemia Study
Part of Heart & circulation clinical trials.
This study looks at small molecules called miRNAs in the blood of people with severe leg artery disease (critical limb ischemia) or belly aortic aneurysm. The goal is to find patterns that may help doctors better understand and treat these conditions.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have critical limb ischemia (CLI) and are scheduled for leg bypass surgery or a major amputation, OR you have an abdominal aortic aneurysm (AAA) and are scheduled for a non-surgical repair (EVAR).
- You are not pregnant.
- You do not have a genetic disease or active cancer.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study examines how immune cells (macrophages) behave differently in patients with blocked arteries in the heart or legs. Understanding this may help doctors develop better treatments for these conditions.
This study follows adults with very poor blood flow to the foot or leg (with wounds or severe pain) who are having a revascularization procedure to improve circulation. It may help doctors understand outcomes after treatment and improve care for people with critical limb ischemia.
This study tests whether stem cells taken from donated fat tissue are safe to inject into people with severe leg circulation problems (critical limb ischemia). It aims to see if the treatment is well tolerated and may help improve blood flow and reduce pain.
This study looks at how best to manage severe leg ischaemia, a condition where blood flow to the leg is dangerously reduced. It mainly involves patients who are planning an intervention, and some participants may also do special heart imaging tests.
This trial studies whether delivering a medicine called temsirolimus directly into the artery during a below-knee revascularization procedure can improve blood flow and outcomes. It may help people with severe leg artery disease who have symptoms like pain while walking or threatened limb tissue loss.
This study tests a new way to restore blood flow to the leg in people who have wounds or dead tissue on their foot and have run out of other treatment options. It's for those who have already tried angioplasty twice without success or have severely hardened small arteries.
Hear when a new Critical Limb Ischemia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.